ADMA Biologics Inc (ADMA)
9.055
-0.04
(-0.49%)
USD |
NASDAQ |
May 16, 16:00
9.05
0.00 (0.00%)
After-Hours: 18:16
ADMA Biologics Free Cash Flow: 15.91M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.91M |
| December 31, 2023 | 3.819M |
| September 30, 2023 | -23.50M |
| June 30, 2023 | -51.39M |
| March 31, 2023 | -61.23M |
| December 31, 2022 | -73.42M |
| September 30, 2022 | -99.43M |
| June 30, 2022 | -98.97M |
| March 31, 2022 | -118.94M |
| December 31, 2021 | -125.88M |
| September 30, 2021 | -124.56M |
| June 30, 2021 | -135.09M |
| March 31, 2021 | -123.81M |
| December 31, 2020 | -114.73M |
| September 30, 2020 | -100.16M |
| June 30, 2020 | -99.02M |
| March 31, 2020 | -92.33M |
| December 31, 2019 | -80.01M |
| September 30, 2019 | -78.37M |
| June 30, 2019 | -65.54M |
| March 31, 2019 | -62.19M |
| December 31, 2018 | -64.77M |
| September 30, 2018 | -60.53M |
| June 30, 2018 | -58.07M |
| March 31, 2018 | -51.53M |
| Date | Value |
|---|---|
| December 31, 2017 | -39.95M |
| September 30, 2017 | -28.20M |
| June 30, 2017 | -22.58M |
| March 31, 2017 | -18.56M |
| December 31, 2016 | -18.34M |
| September 30, 2016 | -18.79M |
| June 30, 2016 | -16.79M |
| March 31, 2016 | -16.39M |
| December 31, 2015 | -15.44M |
| September 30, 2015 | -14.83M |
| June 30, 2015 | -16.01M |
| March 31, 2015 | -16.11M |
| December 31, 2014 | -17.03M |
| September 30, 2014 | -16.53M |
| June 30, 2014 | -14.91M |
| March 31, 2014 | -13.10M |
| December 31, 2013 | -11.08M |
| September 30, 2013 | -9.961M |
| June 30, 2013 | -9.848M |
| March 31, 2013 | -8.165M |
| December 31, 2012 | -6.904M |
| September 30, 2012 | -5.110M |
| June 30, 2012 | -3.014M |
| March 31, 2012 | -2.024M |
| December 31, 2011 | -0.0296M |
Free Cash Flow Range, Past 5 Years
-135.09M
Minimum
Jun 2021
15.91M
Maximum
Mar 2024
-82.33M
Average
-95.65M
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals Inc | -11.77M |
| ANI Pharmaceuticals Inc | 95.06M |
| Ligand Pharmaceuticals Inc | -19.62M |
| Johnson & Johnson | 18.23B |
| Puma Biotechnology Inc | 35.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.218M |
| Cash from Investing (Quarterly) | -2.362M |
| Cash from Financing (Quarterly) | -1.447M |
| Free Cash Flow Per Share (Quarterly) | -0.0194 |
| Free Cash Flow to Equity (Quarterly) | -4.833M |
| Free Cash Flow to Firm (Quarterly) | -1.304M |
| Free Cash Flow Yield | 0.77% |